Background: Treatment of patients with hematologic malignancies is often complicated by severe respiratory infections. Bronchoscopy is generally to be used as a diagnostic tool in order to find a causative pathogen.Objectives: In a prospective study the combination of protected specimen brush (PSB) and protected bronchoalveolar lavage (PBAL) was compared with bronchoal-veolar lavage (BAL) for evaluated feasibility and diagnostic yield in granulocytopenic patients with hematologic malignancies and pulmonary infiltrates.Methods: All. specimens from 63 bronchoscopic procedures (35 BAL and 28 PSB-PBAL) were investigated by cytological examination and various microbiological, tests. If clinically relevant and feasible, based on the clinical cond...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
SummaryBackgroundTreatment of patients with hematologic malignancies is often complicated by severe ...
Background: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
The cancer patient often presents with fever and pulmonary infiltrates, in particular during the cou...
Objectives: To evaluate the clinical utility of bronchoscopy with bronchoalveolar lavage (BAL) for d...
Objectives: To evaluate the clinical utility of bronchoscopy with bronchoalveolar lavage (BAL) for d...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
Background: Treatment of patients with hematologic malignancies is often complicated by severe respi...
SummaryBackgroundTreatment of patients with hematologic malignancies is often complicated by severe ...
Background: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infect...
The cancer patient often presents with fever and pulmonary infiltrates, in particular during the cou...
Objectives: To evaluate the clinical utility of bronchoscopy with bronchoalveolar lavage (BAL) for d...
Objectives: To evaluate the clinical utility of bronchoscopy with bronchoalveolar lavage (BAL) for d...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...
Background: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) ...